Toward a unified survival curve: in regard to Park et al. (IntJ Radiat Oncol Biol Phys 2008;70:847-852) and Krueger et al. (Int J Radiat Oncol Biol Phys 2007;69:1262-1271)

Comment

Brian D Kavanagh et al. Int J Radiat Oncol Biol Phys. 2008.

. 2008 Jul 1;71(3):958-9.

doi: 10.1016/j.ijrobp.2008.03.016.

No abstract available

Comment in

Toward a unified survival curve: in regard to Kavanagh and Newman (Int J Radiat Oncol Biol Phys 2008;71:958-959) and Park et al. (IntJ Radiat Oncol Biol Phys 2008;70:847-852).
McKenna F, Ahmad S. McKenna F, et al. Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):640; author reply 640-1. doi: 10.1016/j.ijrobp.2008.08.063. Int J Radiat Oncol Biol Phys. 2009. PMID: 19147035 No abstract available.

Transition in survival from low-dose hyper-radiosensitivity to increased radioresistance is independent of activation of ATM Ser1981 activity.
Krueger SA, Collis SJ, Joiner MC, Wilson GD, Marples B. Krueger SA, et al. Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1262-71. doi: 10.1016/j.ijrobp.2007.08.012. Int J Radiat Oncol Biol Phys. 2007. PMID: 17967316 Free PMC article.
Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy.
Park C, Papiez L, Zhang S, Story M, Timmerman RD. Park C, et al. Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):847-52. doi: 10.1016/j.ijrobp.2007.10.059. Int J Radiat Oncol Biol Phys. 2008. PMID: 18262098